| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 06/23/2004 | EP1430898A1 Receptor antagonist |
| 06/23/2004 | EP1430894A1 Lymphocytic activation inhibitor and remedial agent for autoimmune disease |
| 06/23/2004 | EP1430126A1 Dna sequences for human angiogenesis genes |
| 06/23/2004 | EP1430120A1 Inhibitors of glycogen synthase kinase-3 (gsk-3) for treating glaucoma |
| 06/23/2004 | EP1430057A2 Substituted 2-pyridinyl-6,7,8,9-tetrahydropyrimido 1,2-a]pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo 1,2-a]pyrimidin-5(1h)one derivatives |
| 06/23/2004 | EP1430056A1 Substituted 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido 1,2-a]pyrimidin-4-one and 7-pyrimidinyl-2,3-dihydroimidazo 1,2-a]pyrimidin-5(1h)one derivatives for neurodegenerative disorders |
| 06/23/2004 | EP1430053A1 Chemical compounds |
| 06/23/2004 | EP1430048A1 3-(arylamino)methylene-1, 3-dihydro-2h-indol-2-ones as kinase inhibitors |
| 06/23/2004 | EP1430043A1 Benzofuran and dihydrobenzofuran derivatives useful as beta-3 adrenoreceptor agonists |
| 06/23/2004 | EP1430042A2 Bicyclic heterocycles as rxr ligands |
| 06/23/2004 | EP1430040A1 Benzothiazepine derivatives |
| 06/23/2004 | EP1430039A2 Aryl derivatives for the treatment of diabetes, hyperlipidemia, hypercholesterolemia and atherosclerosis |
| 06/23/2004 | EP1430027A2 Novel aminoazetidine, -pyrrolidine and -piperidine derivatives |
| 06/23/2004 | EP1430026A1 3-desoxy-vitamin d3 analog esters |
| 06/23/2004 | EP1430019A1 Sphingolipids |
| 06/23/2004 | EP1429845A2 Treatment or prophylaxis of insulin-producing cell graft rejection |
| 06/23/2004 | EP1429842A2 Flavonoids for the treatment of diabetes |
| 06/23/2004 | EP1429784A2 High throughput screening assays using fatty acid synthetic enzymes |
| 06/23/2004 | EP1429782A1 Modulation of vitamin storage |
| 06/23/2004 | EP1429779A2 Androstanes as androgen receptor modulators |
| 06/23/2004 | EP1429776A2 Tricyclic indole derivatives as 5-ht ligands |
| 06/23/2004 | EP1429773A1 Process for making substituted pyrazoles |
| 06/23/2004 | EP1429770A1 New formulations and use thereof |
| 06/23/2004 | EP1429769A1 New formulations and use thereof |
| 06/23/2004 | EP1429767A1 Acylic piperazine and piperidine derivatives which are useful for treating neuronal damage |
| 06/23/2004 | EP1429763A2 NOVEL LIGANDS FOR THE HisB10 Zn2+ SITES OF THE R-STATE INSULIN HEXAMER |
| 06/23/2004 | EP1429762A1 4,5-dihydro-1h-pyrazole derivatives having potent cb1-antagonistic activity |
| 06/23/2004 | EP1429761A1 Novel 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity |
| 06/23/2004 | EP1429757A2 Crystalline forms of fluvastatin sodium |
| 06/23/2004 | EP1429750A2 Inhibition by 3-deoxyflavonoids of t-lymphocyte activation and therapies related thereto |
| 06/23/2004 | EP1429747A1 Core formulation comprising pioglitazone hydrochloride and a biguanide |
| 06/23/2004 | EP1429740A1 Core formulation comprising troglitazone and a biguanide |
| 06/23/2004 | EP1429732A1 A core formulation |
| 06/23/2004 | EP1429629A1 Compositions for appetite control and related methods |
| 06/23/2004 | EP1429628A1 Mixture of base-containing micronutrient substances |
| 06/23/2004 | EP1429617A2 Methods for sterilizing preparations of digestive enzymes |
| 06/23/2004 | EP1429602A1 Methods for treating disorders using plant extracts |
| 06/23/2004 | EP1274698B1 Percyquinnin, a process for its production and its use as a pharmaceutical |
| 06/23/2004 | EP1265985A4 Pancreatic islet cell growth factors |
| 06/23/2004 | EP1230227B1 Benzoxa-and benzothiazolyl sulfamates and their use as steroid sulfatase inhibitors |
| 06/23/2004 | EP1171573B1 Arpe-19 as a platform cell line for encapsulated cell-based delivery |
| 06/23/2004 | EP1076644B1 N-substituted aminotetralins as ligands for the neuropeptide y y5 receptor useful in the treatment of obesity and other disorders |
| 06/23/2004 | EP1066283B1 Substituted indolealkanoic acids |
| 06/23/2004 | EP1036075B1 Substituted thiazolidinedione and oxazolidinedione having antidiabetic, hypolipidemia and antihypertensive properties |
| 06/23/2004 | EP1024801B1 Method for regulating size and growth of vascularized normal tissue |
| 06/23/2004 | CN1507456A Fibre containing composition for enteral nutrition |
| 06/23/2004 | CN1507455A Food product with prolonged energy release |
| 06/23/2004 | CN1507442A Furan and thiophene derivatives that activate human peroxisome proliferator activated receptors |
| 06/23/2004 | CN1507437A Aralkylpiperazines with serotonin 5-HTIA activity |
| 06/23/2004 | CN1507434A Novel 4-anilinoquinoline-3-carboxamides compound |
| 06/23/2004 | CN1507362A Method of preventing type 2 diabetes with aerosolized insulin |
| 06/23/2004 | CN1506359A Coumarin amide derivative and its prepn, medicinal composition and use |
| 06/23/2004 | CN1506114A Application of aliphatic diphenol lysine insulin in treating diabetes |
| 06/23/2004 | CN1506113A Prepn process of hydrogel prepn of recombined platelet derived growth factor |
| 06/23/2004 | CN1506112A Hydrogel prepn of recombined platelet derived growth factor |
| 06/23/2004 | CN1506106A Sinowilsonia henryi extract and its prepn process, composition and use |
| 06/23/2004 | CN1506090A Rheum emodi wall extract and medicine composition with the extract as active component |
| 06/23/2004 | CN1506079A Diabetes treating medicine |
| 06/23/2004 | CN1506077A Liver-protecting and blood fat-reducing product |
| 06/23/2004 | CN1506073A Application of zinc salt in medicine for treating diabetes |
| 06/23/2004 | CN1506072A Lecithin-containing drinking water for children |
| 06/23/2004 | CN1506069A Weixitie-containing drinking water for children |
| 06/23/2004 | CN1506068A Calcium-containing drinking water for children |
| 06/23/2004 | CN1506066A Cell growth regulating factor oral liquid and its prepn process |
| 06/23/2004 | CN1506049A Medicine for treating diabetes and its complication |
| 06/23/2004 | CN1506048A Application of levo histidine in treating diabetes |
| 06/23/2004 | CN1506047A Effervescent vitamin C granule and its prepn |
| 06/23/2004 | CN1506046A Active compound of Baojiwan pill for resisting diarrhea and reducing gastrointestinal illness |
| 06/23/2004 | CN1506033A Depressing and antilipemic head wash |
| 06/23/2004 | CN1505980A Nutritious composition |
| 06/23/2004 | CN1505979A Nutritious composition |
| 06/23/2004 | CN1505978A Nutritious constituents |
| 06/23/2004 | CN1505977A Nutritious constituents |
| 06/23/2004 | CN1154726C OB protein derivatives having prolonged half-life |
| 06/23/2004 | CN1154648C Stable crystal salt of 5-methyl tetrahydrofolic acid |
| 06/23/2004 | CN1154646C Benzisozazoles and phenones as alpha antagonist |
| 06/23/2004 | CN1154508C Stimulation of host defence mechanisms against viral challenges |
| 06/23/2004 | CN1154505C Use of gastrointstinal lipase inhibitors |
| 06/23/2004 | CN1154498C Process for preparation of oral pharmaceutical compositions comprising biphosphonates |
| 06/23/2004 | CN1154490C Celecoxib compositions |
| 06/22/2004 | US6753432 Process for the preparation of thiazolidinedione derivatives |
| 06/22/2004 | US6753412 Human Eag2 |
| 06/22/2004 | US6753347 Intermediates for the synthesis of benzimidazole derivatives and a process for the preparation thereof |
| 06/22/2004 | US6753346 CETP activity inhibitor |
| 06/22/2004 | US6753336 Melanin concentrating hormone receptor ligands |
| 06/22/2004 | US6753332 Sulfonyl heteroaryl triazoles as anti-inflammatory/analgesic agents |
| 06/22/2004 | US6753325 Comprises vitamin d3 for controlling cell differentiation and/or cell proliferation |
| 06/22/2004 | US6753313 Multimeric Apoa-I agonist compounds |
| 06/22/2004 | US6753153 Markers for identification and isolation of pancreatic islet α and β progenitors |
| 06/22/2004 | US6753150 Detection of modulators of advanced glycation end product activity; obtain sample containing advanced glycation end product activity, incubate with peptide monitor adjustment in activity, adjustment in activity indicates modulator |
| 06/22/2004 | US6753140 Nucleotide sequences coding preferential polypeptide for use in the treatment of diabetes and eating disorders |
| 06/22/2004 | US6752981 Cyclic phosph(oramid)ate prodrugs having alcohol, amine, orthiol groups attached to the phosphorus in the c3n2p or c3o2p ring |
| 06/17/2004 | WO2004050656A1 1,3-dihydroimidazole fused-ring compound |
| 06/17/2004 | WO2004050652A1 Novel azole derivatives |
| 06/17/2004 | WO2004050651A1 Anilinopyrazole derivatives useful for the treatment of diabetes |
| 06/17/2004 | WO2004050650A1 Anilinopyrazole derivatives useful for the treatment of diabetes |
| 06/17/2004 | WO2004050635A2 Imidazol derivatives having affinity for alpha 2 receptors activity |
| 06/17/2004 | WO2004050610A2 Modulators of melanocortin receptor |
| 06/17/2004 | WO2004050122A1 Preventive or remedy for diseases caused by hyperglycemia |
| 06/17/2004 | WO2004050118A1 Cysteine protease inhibitor |